- Ultragenyx Pharmaceutical (NASDAQ:RARE): Q4 EPS of -$1.89 beats by $0.10.
- Revenue of $2.41M beats by $2.23M.
- Shares -0.12%.
- Press Release
Ultragenyx Pharmaceutical beats by $0.10, beats on revenue
Recommended For You
More Trending News
About RARE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
RARE | - | - |
Ultragenyx Pharmaceutical Inc. |